ARTIVION, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ARTIVION, INC. (AORT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $5.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-18
- ARTIVION, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $5.31M, a 16.45% increase from fiscal 2024.
- ARTIVION, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $4.56M.
- ARTIVION, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$24.66M.
- ARTIVION, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$13.80M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $5.31M 10-K · filed 2026-02-18 |
| 2024-12-31 | $4.56M 10-K · filed 2026-02-18 |
| 2023-12-31 | -$24.66M 10-K · filed 2026-02-18 |
| 2022-12-31 | -$13.80M 10-K · filed 2025-02-28 |
| 2021-12-31 | -$10.26M 10-K · filed 2024-02-23 |
| 2020-12-31 | -$11.44M 10-K · filed 2023-02-23 |
| 2019-12-31 | $6.37M 10-K · filed 2022-02-22 |
| 2018-12-31 | $4.56M 10-K · filed 2021-02-23 |
| 2017-12-31 | $5.09M 10-K · filed 2020-02-19 |
| 2016-12-31 | $17.87M 10-K · filed 2019-02-26 |
| 2015-12-31 | $5.70M 10-K · filed 2018-03-09 |
| 2014-12-31 | $8.35M 10-K · filed 2017-02-16 |
| 2013-12-31 | $23.00M 10-K · filed 2016-02-16 |
| 2012-12-31 | $11.69M 10-K · filed 2015-02-17 |
| 2011-12-31 | $11.24M 10-K · filed 2014-02-21 |
| 2010-12-31 | $6.94M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |